The rapid spread of psychedelics throughout society is prompting fascinating discussions around the political aspects of these substances and their study. Questions about their capacity to shift people’s ideologies towards liberalism and the suspicion elicited by the actors financing psychedelic trials have contributed to this heated political debate. Are liberal or progressive ideas inherent to […]

Laboratory research at Johns Hopkins School of Medicine has included administering psilocybin to healthy volunteers, psychologically distressed cancer patients, cigarette smokers seeking abstinence, ordained clergy, as well as beginner and long-term meditators. The results from several studies suggest that mystical-type experiences appear to mediate sustained positive changes in attitudes, mood, and behavior. However, individuals responding […]

By Aleksi Hupli Although controversial only a few years ago, there is ample evidence that psychedelics can help in the fight against addictions (use disorders). Over the past decades, there have been multiple studies looking into the workings of psychedelics in the field of addiction. Multiple trials have concluded that there are indeed possibilities to […]

Psychiater Tijmen Bostoen werkt als trauma-expert in Centrum ‘45, waar binnenkort een gerandomiseerd gecontroleerd onderzoek (of RCT) van start gaat met mdma in de behandeling van PTSS. Daarnaast behandelt Bostoen sinds dit jaar patiënten die zowel een psychotrauma als een depressie hebben met ketamine, aan het LUMC. Daarmee is hij één van de weinige psychiaters […]

MDMA is on the brink of becoming accepted as a legal medication in therapy. What will be its applications, its legal status, and what did its journey look like?